Amplicon details |
||
Amplicon: |
173 bp | |
1 ggatctcctg tcatctcacc ttgctcctgc cgagaaagta tccatcatgg 51 ctgatgcaat gcggcggctg catacgcttg atccggctac ctgcccattc 101 gaccaccaag cgaaacatcg catcgagcga gcacgtactc ggatggaagc 151 cggtcttgtc gatcaggatg atc |
||
| Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
|---|---|---|---|---|---|---|---|
| NRN_CS362347 | nrnl1 | Sequence 28 from Patent WO2004108933. | 7333 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CS163804 | nrnl1 | Sequence 15 from Patent WO200508308... | 4863 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CS144283 | nrnl1 | Sequence 62 from Patent WO200507337... | 2505 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| JN948795.1 | emblreltgn | Mus musculus targeted non-condition... | 39631 bp | Mus musculus | QL-ELE-00-003 | 173 bp | View |
| NRN_BD263375 | nrnl1 | Compositions and methods for use in... | 8123 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CQ887764 | nrnl1 | Sequence 45 from Patent WO200406335... | 19491 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CQ759499 | nrnl1 | Sequence 15 from Patent WO2003104463. | 10158 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CS355370 | nrnl1 | Sequence 36 from Patent WO200606971... | 6389 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| JN946747.1 | nt | Mus musculus targeted KO-first, con... | 40115 bp | Mus musculus | QL-ELE-00-003 | 173 bp | View |
| JN948796.1 | emblreltgn | Mus musculus targeted KO-first, con... | 39323 bp | Mus musculus | QL-ELE-00-003 | 173 bp | View |
| NRN_CQ887757 | nrnl1 | Sequence 38 from Patent WO200406335... | 17238 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| JN946748.1 | nt | Mus musculus targeted non-condition... | 37883 bp | Mus musculus | QL-ELE-00-003 | 173 bp | View |
| OQ749646.1 | nt | Vector pcDNA3.1(+)-VEE-Luc-deltaPS9... | 15401 bp | Vector pcDNA3.1(+)-VEE-Luc-deltaPS9 | QL-ELE-00-003 | 173 bp | View |
| DI095642.1 | emblrelpat | METHOD FOR THE GENETIC MODIFICATION... | 16103 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CS476615 | nrnl1 | Sequence 14 from Patent WO200613660... | 10515 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CS457857 | nrnl1 | Sequence 29 from Patent WO200612297... | 6086 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CS376392 | nrnl1 | Sequence 6 from Patent WO2006074956. | 6085 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CS476134 | nrnl1 | Sequence 7 from Patent WO2006024867... | 7907 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CQ803123 | nrnl1 | Sequence 9 from Patent WO2004035782. | 4641 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
| NRN_CS086288 | nrnl1 | Sequence 10 from Patent WO200504272... | 7174 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.